Andries E Braat
Overview
Explore the profile of Andries E Braat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goudsmit B, Putter H, Tushuizen M, Vogelaar S, Pirenne J, Ian P J A, et al.
Hepatology
. 2025 Feb;
81(3):E112.
PMID: 39960204
No abstract available.
2.
Hendriks P, Rietbergen D, van Erkel A, Coenraad M, Arntz M, Bennink R, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(7):2085-2097.
PMID: 38329507
Purpose: The aim of this study was to investigate the biodistribution of (super-)selective trans-arterial radioembolization (TARE) with holmium-166 microspheres (Ho-MS), when administered as adjuvant therapy after RFA of HCC 2-5...
3.
Goudsmit B, Prosepe I, Tushuizen M, Mazzaferro V, Alwayn I, van Hoek B, et al.
JHEP Rep
. 2023 Nov;
5(12):100907.
PMID: 38034881
Background & Aims: In the USA, inequal liver transplantation (LT) access exists between patients with and without hepatocellular carcinoma (HCC). Survival benefit considers survival without and with LT and could...
4.
Nooijen L, de Boer M, Braat A, Dewulf M, den Dulk M, Hagendoorn J, et al.
Eur J Surg Oncol
. 2023 Oct;
51(2):107117.
PMID: 37880001
Background: Currently, no practical definition of potentially resectable, borderline or unresectable perihilar cholangiocarcinoma (pCCA) is available. Aim of this study was to define criteria to categorize patients for use in...
5.
Chotkan K, Hilbrands L, Putter H, Konjin C, Schaefer B, Beenen L, et al.
Transplantation
. 2023 Sep;
108(1):252-260.
PMID: 37728569
Background: The administration of contrast medium is associated with acute kidney injury; however, the effect of exposure of a deceased organ donor to contrast medium on kidney transplant outcomes has...
6.
van Dooren M, de Savornin Lohman E, Brekelmans E, Vissers P, Erdmann J, Braat A, et al.
World J Surg Oncol
. 2023 Jan;
21(1):6.
PMID: 36641472
Background: Disseminated disease (DD) is often found at (re-)exploration in gallbladder cancer (GBC) patients. We aimed to assess the yield of staging laparoscopy (SL) and identify predictors for DD. Methods:...
7.
Hendriks P, Rietbergen D, van Erkel A, Coenraad M, Arntz M, Bennink R, et al.
Cardiovasc Intervent Radiol
. 2022 May;
45(8):1057-1063.
PMID: 35618860
Purpose: To investigate the biodistribution of holmium-166 microspheres (Ho-MS) when administered after radiofrequency ablation (RFA) of early-stage hepatocellular carcinoma (HCC). The aim is to establish a perfused liver administration dose...
8.
de Boer J, Putter H, Blok J, Cambridge N, van den Berg S, Vogelaar S, et al.
Exp Clin Transplant
. 2021 Nov;
19(11):1163-1172.
PMID: 34812707
Objectives: The utilization of liver allografts could be optimized if nonacceptance is predicted. This study aimed to evaluate the prognostic ability of an updated Discard Risk Index in Eurotransplant. Materials...
9.
Goudsmit B, Braat A, Tushuizen M, Coenraad M, Vogelaar S, Alwayn I, et al.
JHEP Rep
. 2021 Nov;
3(6):100369.
PMID: 34765960
Background & Aims: Acute-on-chronic liver failure (ACLF) is usually associated with a precipitating event and results in the failure of other organ systems and high short-term mortality. Current prediction models...
10.
Goudsmit B, Braat A, Tushuizen M, Vogelaar S, Pirenne J, Alwayn I, et al.
Am J Transplant
. 2021 Jun;
21(11):3583-3592.
PMID: 34174149
Liver function is measured regularly in liver transplantation (LT) candidates. Currently, these previous disease development data are not used for survival prediction. By constructing and validating joint models (JMs), we...